Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Your are on :  Markets   |  News Analysis    |  Corporate Results   |Detailed News   
Back
Johnson Pharmacare reports standalone net loss of Rs 0.36 crore in the March 2022 quarter
25-May-22   17:36 Hrs IST

Net loss of Johnson Pharmacare reported to Rs 0.36 crore in the quarter ended March 2022 as against net profit of Rs 0.10 crore during the previous quarter ended March 2021. There were no Sales reported in the quarter ended March 2022 as against Rs 0.76 crore during the previous quarter ended March 2021.

For the full year,net profit reported to Rs 0.10 crore in the year ended March 2022. There were no net profit/loss reported during the previous year ended March 2021. Sales rose 328.95% to Rs 3.26 crore in the year ended March 2022 as against Rs 0.76 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales00.76 -100 3.260.76 329
OPM %013.16 -4.290 -
PBDT-0.320.10 PL 0.140 0
PBT-0.320.10 PL 0.140 0
NP-0.360.10 PL 0.100 0

Powered by Capital Market - Live News

Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)